Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker - with an Emphasis on Cervical Cancer
Favorite
Share
More Options
21

Open in WPS to view all 21 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
